I knew those Russian's had said something awhile back about a cure and with your effort now, it is clearer and very plausible that they were speaking about brilacidin... Thanks maxinvest... Good Job!
Molodetz(strong work) maxinvest! This is one of the most bizarre developments here ever. How to figure it? Trial was supposed to be 160 and they say 106 here- a misprint? Numbers reversed? 54 patients for the US? Why? That'd be exactly 2/3 there and 1/3 here. This will make conclusions harder and not easier for us shareholders. When Russia says what its vaccine results are, do you believe them? Of course not. No one trusts the Russians about anything.
For IP to run 2/3 of its trial through Russia is a mistake, unless this was forced on IP and B as part of a partnership. Is that the next announcement?
This is too weird. The trial started in Russia and no one bothers to inform the shareholders.